EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma - Martija, Antoni Andreu; Krauß, Alexandra; Bächle, Natalie; Doth, Laura; Christians, Arne; Krunic, Damir; Schneider, Martin; Helm, Dominic; Will, Rainer D.; Hartmann, Christian; Herold-Mende, Christel; Deimling, Andreas von; et al. (Acta Neuropathologica Communications, 2023)
Gesehen am 05.06.2024